Sarilumab, a fully human monoclonal antibody against IL-6R alpha in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial

Author(s):
Huizinga, T.W.J. (0000-0001-7033-7520); Fleischmann, R.M.; Jasson, M.; Radin, A.R.; Adelsberg, J. van; Fiore, S.; Huang, X.H.; Yancopoulos, G.D.; Stahl, N.; Genovese, M.C.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-09-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, no. 9, p. 1626-1634
hdl
1887/103578
doi
10.1136/annrheumdis-2013-204405